Synthetic molecule improves mitochondrial function in ALS models and patient-derived stem cells

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease in which motor neurons are gradually lost, leading to muscle weakness and, as the disease advances, difficulty breathing and swallowing. Existing medicines can slow disease progression to some extent, but no treatment has been established that fundamentally reverses the disease process. Mitochondrial dysfunction is considered a potential therapeutic target because mitochondria play a central role in cellular energy production and are frequently impaired in ALS.

Read it at Medical Xpress ↗

← Front page